Related references
Note: Only part of the references are listed.Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study
Maja Niksic et al.
CANCER COMMUNICATIONS (2023)
MilCanEpi: Increased Capability for Cancer Care Research in the Department of Defense
Yvonne L. Eaglehouse et al.
JCO Clinical Cancer Informatics (2023)
Age and prognosis in patients with pancreatic cancer: a population-based study
Jelle C. van Dongen et al.
ACTA ONCOLOGICA (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Gender-specific side effects of chemotherapy in pancreatic cancer patients
Silvia De Francia et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)
Tumor Location in the Pancreatic Tail Is Associated with Decreased Likelihood of Receiving Chemotherapy for Pancreatic Adenocarcinoma
Justin A. Drake et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2022)
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
Hakon Blomstrand et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)
Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients
Hyun Ae Jung et al.
CHEMOTHERAPY (2021)
Pancreatic Adenocarcinoma, Version 2.2021
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Young Adults With Pancreatic Cancer National Trends in Treatment and Outcomes
Olatunji B. Alese et al.
PANCREAS (2020)
Consolidation of Cancer Registry and Administrative Claims Data on Cancer Diagnosis and Treatment in the US Military Health System
Yvonne L. Eaglehouse et al.
JCO CLINICAL CANCER INFORMATICS (2020)
Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
Michael D. Watson et al.
JOURNAL OF PANCREATIC CANCER (2020)
Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types
Chenyue Zhang et al.
JAMA NETWORK OPEN (2020)
The US Military Health System: Promoting Readiness And Providing Health Care
Terri Tanielian et al.
HEALTH AFFAIRS (2019)
A Military Health System For The Twenty-First Century
Terry Adirim
HEALTH AFFAIRS (2019)
Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
Monica I. Dumbrava et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Adapting the Elixhauser Comorbidity Index for Cancer Patients
Hemalkumar B. Mehta et al.
CANCER (2018)
Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014
Libby Ellis et al.
JAMA ONCOLOGY (2018)
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act
Ryan D. Nipp et al.
JAMA ONCOLOGY (2018)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management
Michael J. Hassett et al.
MEDICAL CARE (2017)
Racial and Ethnic Disparities in Health and Health Care
Sarahn M. Wheeler et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2017)
Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Huaqiang Zhou et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy et al.
EUROPEAN JOURNAL OF CANCER (2016)
Immortal time bias in observational studies of time-to-event outcomes
Mark Jones et al.
JOURNAL OF CRITICAL CARE (2016)
Access to Cancer Care and General Medical Care Services Among Cancer Survivors in the United States: An Analysis of 2011 Medical Expenditure Panel Survey Data
Janet S. de Moor et al.
PUBLIC HEALTH REPORTS (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection
Daniel J. Kagedan et al.
HPB (2016)
Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER database
Xiao-Dong Wang et al.
ONCOTARGET (2016)
Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer
Mia Shapiro et al.
JAMA SURGERY (2016)
Development of a claims-based algorithm to identify colorectal cancer recurrence
Anjali D. Deshpande et al.
ANNALS OF EPIDEMIOLOGY (2015)
Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus
Chen Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
Yixiang Mao et al.
SCIENTIFIC REPORTS (2015)
Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base
Nabin Khanal et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients With Cancer According to Insurance Status
Gary V. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts
Michael J. Hassett et al.
MEDICAL CARE (2014)
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas
Steven M. Strasberg et al.
HPB (2014)
Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System
Sukhyung Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis
Bunzo Nakata et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
A Multi-institutional Study of Pancreatic Cancer in Harris County, Texas: Race Predicts Treatment and Survival
Curtis J. Wray et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Pancreatic Resection A Key Component to Reducing Racial Disparities in Pancreatic Adenocarcinoma
Melissa M. Murphy et al.
CANCER (2009)
Survivor Treatment Selection Bias and Outcomes Research A Case Study of Surgery in Infective Endocarditis
Raymond W. Sy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2009)
Prognostic Factors and Adjuvant Chemoradiation Therapy After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
Dong Do You et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in california
Jason A. Zell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Measuring disease-free survival and cancer relapse using medicare claims from CALGB breast cancer trial participants (companion to 9344)
Elizabeth B. Lamont et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Access and equity to cancer care in the USA: a review and assessment
LA Siminoff et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Differences in survival by histologic type of pancreatic cancer
MD Fesinmeyer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Share Paper
